DK0684839T3 - Fremgangsmåde til fremstilling af kolloidale vandige opløsninger af tungtopløselige aktive stoffer - Google Patents

Fremgangsmåde til fremstilling af kolloidale vandige opløsninger af tungtopløselige aktive stoffer

Info

Publication number
DK0684839T3
DK0684839T3 DK94906225T DK94906225T DK0684839T3 DK 0684839 T3 DK0684839 T3 DK 0684839T3 DK 94906225 T DK94906225 T DK 94906225T DK 94906225 T DK94906225 T DK 94906225T DK 0684839 T3 DK0684839 T3 DK 0684839T3
Authority
DK
Denmark
Prior art keywords
pct
active substances
preparation
aqueous solutions
solution
Prior art date
Application number
DK94906225T
Other languages
English (en)
Inventor
Joerg Rosenberg
Cynthia Romerdhal
Juergen Heberger
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Application granted granted Critical
Publication of DK0684839T3 publication Critical patent/DK0684839T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK94906225T 1993-02-18 1994-02-07 Fremgangsmåde til fremstilling af kolloidale vandige opløsninger af tungtopløselige aktive stoffer DK0684839T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4305003A DE4305003A1 (de) 1993-02-18 1993-02-18 Verfahren zur Herstellung kolloidaler wäßriger Lösungen schwer löslicher Wirkstoffe
PCT/EP1994/000332 WO1994019018A1 (de) 1993-02-18 1994-02-07 Verfahren zur herstellung kolloidaler wässriger lösungen schwer löslicher wirkstoffe

Publications (1)

Publication Number Publication Date
DK0684839T3 true DK0684839T3 (da) 1999-06-14

Family

ID=6480792

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94906225T DK0684839T3 (da) 1993-02-18 1994-02-07 Fremgangsmåde til fremstilling af kolloidale vandige opløsninger af tungtopløselige aktive stoffer

Country Status (9)

Country Link
US (1) US5626864A (da)
EP (1) EP0684839B1 (da)
JP (1) JPH08506590A (da)
AT (1) ATE171377T1 (da)
CA (1) CA2155085C (da)
DE (2) DE4305003A1 (da)
DK (1) DK0684839T3 (da)
ES (1) ES2121190T3 (da)
WO (1) WO1994019018A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US20040256749A1 (en) * 2000-12-22 2004-12-23 Mahesh Chaubal Process for production of essentially solvent-free small particles
US9700866B2 (en) * 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US6884436B2 (en) * 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US8067032B2 (en) * 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US20040022862A1 (en) * 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
US6951656B2 (en) * 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6977085B2 (en) * 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US6869617B2 (en) * 2000-12-22 2005-03-22 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
JP2005504090A (ja) * 2001-09-26 2005-02-10 バクスター・インターナショナル・インコーポレイテッド 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
US20060003012A9 (en) * 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
JP2007520555A (ja) * 2004-02-05 2007-07-26 バクスター・インターナショナル・インコーポレイテッド 自己安定化剤の使用により調製された分散剤
US20060280787A1 (en) * 2005-06-14 2006-12-14 Baxter International Inc. Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
US20060280786A1 (en) * 2005-06-14 2006-12-14 Rabinow Barrett E Pharmaceutical formulations for minimizing drug-drug interactions
BRPI0618661A2 (pt) * 2005-11-15 2011-09-06 Baxter Int composições de inibidores de lipoxigenase
US20090152176A1 (en) * 2006-12-23 2009-06-18 Baxter International Inc. Magnetic separation of fine particles from compositions
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5635169B2 (da) * 1974-02-14 1981-08-15
DE2914788A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
DE3010041C2 (de) * 1980-03-15 1985-01-03 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittel zur Behandlung von parasitärem Wurmbefall
DE3218027A1 (de) * 1982-05-13 1983-11-17 A. Nattermann & Cie GmbH, 5000 Köln Phospholipidloesungen
US5008050A (en) * 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
AU598958B2 (en) * 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
AU6461090A (en) * 1989-10-30 1991-05-02 Abbott Laboratories Injectable formulation for lipophilic drugs
DE4015108A1 (de) * 1990-05-11 1991-11-14 Leopold Pharma Gmbh Stabile emulsion zur applikation pharmakologisch aktiver wirkstoffe
DE4124252A1 (de) * 1991-07-22 1993-01-28 Knoll Ag Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung

Also Published As

Publication number Publication date
DE4305003A1 (de) 1994-08-25
ES2121190T3 (es) 1998-11-16
WO1994019018A1 (de) 1994-09-01
EP0684839A1 (de) 1995-12-06
CA2155085A1 (en) 1994-09-01
CA2155085C (en) 2003-10-28
ATE171377T1 (de) 1998-10-15
EP0684839B1 (de) 1998-09-23
US5626864A (en) 1997-05-06
JPH08506590A (ja) 1996-07-16
DE59406975D1 (de) 1998-10-29

Similar Documents

Publication Publication Date Title
DK0684839T3 (da) Fremgangsmåde til fremstilling af kolloidale vandige opløsninger af tungtopløselige aktive stoffer
CA2164840A1 (fr) Procede de degommage d'un corps gras et corps gras ainsi obtenu
SE9502244D0 (sv) A composition and a process for the preparation thereof
AU697767B2 (en) Topically applicable pharmaceutical composition, process of manufacture, and use of the composition
ATE158340T1 (de) Flüssigkristalline wässrige tensidzubereitung
AU2001260910A1 (en) A microemulsion containing a branched alkyl glycoside
DK0833640T3 (da) Farmaceutisk præparat indeholdende lamotrigin
AU7307496A (en) Water-redispersible granules including a liquid active material and a non-ionic alkoxyl-type surfactant
FI963251A0 (fi) Farmaseuttinen valmiste, jossa on plasminogeeniaktivaattoreita
AU6122994A (en) Hiv protease inhibitors and their preparation
MX9300707A (es) Composiciones liposomaticas topicas que comprenden piroxicam y procedimiento para su preparacion.
EE9700218A (et) Trombiini inhibiitorit sisaldav säilituskindel vesilahus süstimiseks
AR003206A1 (es) Un procedimiento para la preparacion de un aderezo.
NO981718L (no) Blanding for behandling av fjµrfestr°
ES2137487T3 (es) Procedimiento para la preparacion de proteinas de una sustancia con contenido en proteinas.
ATE103803T1 (de) Verfahren zur herstellung waessriger mischmicelloesungen.
ES2079973T3 (es) Empleo de una mezcla solubilizadora para la obtencion de disoluciones acuosas fuertemente alcalinas de agentes tensioactivos no ionicos.
JPH03127731A (ja) ビタミンｅの可溶化方法およびビタミンｅ製剤
DE59305354D1 (de) Spritzfertige azosemid-injektionslösungen
KR950703342A (ko) 수용액
MX9803337A (es) Metodos para incorporar una sustancia hidrofobica en una solucion acuosa.
DK0696170T3 (da) Vandige endosulfansuspensionskoncentrater